Health / Medical Topics

    VHL-59: 116-128 Peptide

    A peptide vaccine consisting of amino acids 116 through 128 derived from the tumor suppressor protein Von Hippel-Lindau (VHL) with a frameshift mutation. As a cancer vaccine, VHL-59: 116-128(FrSh116-128) peptide may stimulate a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing this VHL mutant protein. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A peptide vaccine consisting of amino acids 65 through 76 derived from the tumor suppressor protein Von Hippel-Lindau (VHL) with a glycine…
    Human VHL wild-type allele is located within 3p26-p25 and is approximately 10 kb in length. This allele, which encodes von Hippel-Lindau disease…
    A rare inherited disorder in which blood vessels grow abnormally in the eyes, brain, spinal cord, adrenal glands, or other parts of…
    This gene is involved in transcriptional repression and protein degradation.
    A question associated with the VFQ25-Self Administered Format questionnaire.
    Visual Functioning Questionnaire 25-Self Administered Format Version 2000 (VFQ25-Self Administered Format) Responses to Vision Problems: I worry about doing things that will…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact